Cargando…
单中心晚期非小细胞肺癌免疫治疗真实世界数据分析
BACKGROUND AND OBJECTIVE: In recent years, a number of clinical trials have shown that immunocheckpoint inhibitors (ICI) have brought survival benefits to patients with advanced non-small cell lung cancer (NSCLC), however, such clinical trials comprise cohorts selected based on strict and complex en...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885419/ https://www.ncbi.nlm.nih.gov/pubmed/31771737 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.11.02 |